These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 3756830)

  • 1. Systemic aspergillosis as cause of myocardial infarction.
    Andersson BS; Luna MA; McCredie KB
    Cancer; 1986 Nov; 58(9):2146-50. PubMed ID: 3756830
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Myocardial infarction caused by Aspergillus embolization in a patient with aplastic anemia.
    Itoh M; Takahashi M; Mori M; Tamekiyo H; Yoshida H; Yago K; Shimada H; Arai K
    Intern Med; 2006; 45(8):547-50. PubMed ID: 16702749
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Aspergillus coronary embolization causing acute myocardial infarction.
    Laszewski M; Trigg M; de Alarcon P; Giller R
    Bone Marrow Transplant; 1988 May; 3(3):229-33. PubMed ID: 3048489
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Aspergillus fumigatus, a rare cause of fatal coronary artery occlusion.
    Kuijer PM; Kuijper EJ; van den Tweel JG; van der Lelie J
    Infection; 1992; 20(1):45-7. PubMed ID: 1563813
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Recognition and successful management in pulmonary aspergillosis in leukemia.
    Sinclair AJ; Rossof AH; Coltman CA
    Cancer; 1978 Oct; 42(4):2019-24. PubMed ID: 709546
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pulmonary and myocardial infarction secondary to arterial occlusion by Aspergillus fumigatus in ANLL.
    Landonio G; Nosari A; Gargantini L; De Cataldo F; Oreste P
    Haematologica; 1989; 74(5):503-5. PubMed ID: 2511122
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Changes in the natural history of invasive pulmonary aspergillosis in neutropenic leukemic patients.
    Ruchlemer R; Yinnon AM; Hershko C
    Isr J Med Sci; 1996 Nov; 32(11):1089-92. PubMed ID: 8960078
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic factors of invasive pulmonary aspergillosis in leukemic patients.
    Ribrag V; Dreyfus F; Venot A; Leblong V; Lanore JJ; Varet B
    Leuk Lymphoma; 1993 Jul; 10(4-5):317-21. PubMed ID: 8220129
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Refractory Aspergillus pneumonia in patients with acute leukemia: successful therapy with combination caspofungin and liposomal amphotericin.
    Aliff TB; Maslak PG; Jurcic JG; Heaney ML; Cathcart KN; Sepkowitz KA; Weiss MA
    Cancer; 2003 Feb; 97(4):1025-32. PubMed ID: 12569602
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Invasive pulmonary aspergillosis prior to BMT in acute leukemia patients does not predict a poor outcome.
    Richard C; Romón I; Baro J; Insunza A; Loyola I; Zurbano F; Tapia M; Iriondo A; Conde E; Zubizarreta A
    Bone Marrow Transplant; 1993 Sep; 12(3):237-41. PubMed ID: 8241983
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Combination amphotericin B-rifampin therapy for pulmonary aspergillosis in a leukemic patient.
    Ribner B; Keusch GT; Hanna BA; Perloff M
    Chest; 1976 Nov; 70(5):681-3. PubMed ID: 789031
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In-vitro testing of susceptibility to amphotericin B is a reliable predictor of clinical outcome in invasive aspergillosis.
    Lass-Flörl C; Kofler G; Kropshofer G; Hermans J; Kreczy A; Dierich MP; Niederwieser D
    J Antimicrob Chemother; 1998 Oct; 42(4):497-502. PubMed ID: 9818749
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Aspergillosis in immunocompromised children with acute myeloid leukemia and bone marrow aplasia. Report of two cases.
    de Aquino MZ; Brasciner A; Cristófani LM; Maluf PT; Odone Filho V; Marques HH; Heins-Vaccari EM; Lacaz Cda S; de Melo NT
    Rev Inst Med Trop Sao Paulo; 1994; 36(5):465-9. PubMed ID: 7569615
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Invasive esophageal aspergillosis associated with acute myelogenous leukemia: successful therapy with combination caspofungin and liposomal amphotericin B.
    Alioglu B; Avci Z; Canan O; Ozcay F; Demirhan B; Ozbek N
    Pediatr Hematol Oncol; 2007; 24(1):63-8. PubMed ID: 17130115
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Aspergillus pneumonia in adult patients with acute leukemia.
    Cadogan S; Miller S
    Clin J Oncol Nurs; 2014 Apr; 18(2):243-6. PubMed ID: 24675261
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Invasive aspergillosis. Disease spectrum, treatment practices, and outcomes. I3 Aspergillus Study Group.
    Patterson TF; Kirkpatrick WR; White M; Hiemenz JW; Wingard JR; Dupont B; Rinaldi MG; Stevens DA; Graybill JR
    Medicine (Baltimore); 2000 Jul; 79(4):250-60. PubMed ID: 10941354
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment of invasive fungal sinusitis with liposomal amphotericin B: a report of four cases.
    Sungkanuparph S; Sathapatayavongs B; Kunachak S; Luxameechanporn T; Cheewaruangroj W
    J Med Assoc Thai; 2001 Apr; 84(4):593-601. PubMed ID: 11460976
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Invasive pulmonary aspergillosis with cerebral abscess in a patient with idiopathic thrombocytopenic purpura.
    Tsai HC; Lee SS; Wann SR; Chen YS; Wang JS; Liu YC
    J Chin Med Assoc; 2006 Jun; 69(6):278-81. PubMed ID: 16863015
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Liposomal amphotericin B for the treatment of systemic fungal infections in patients with cancer: a preliminary study.
    Lopez-Berestein G; Fainstein V; Hopfer R; Mehta K; Sullivan MP; Keating M; Rosenblum MG; Mehta R; Luna M; Hersh EM
    J Infect Dis; 1985 Apr; 151(4):704-10. PubMed ID: 3973417
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Aspergillus terreus: an emerging amphotericin B-resistant opportunistic mold in patients with hematologic malignancies.
    Hachem RY; Kontoyiannis DP; Boktour MR; Afif C; Cooksley C; Bodey GP; Chatzinikolaou I; Perego C; Kantarjian HM; Raad II
    Cancer; 2004 Oct; 101(7):1594-600. PubMed ID: 15378491
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.